| Q37207994 | Analysis of oxidative stress biomarkers using a simultaneous competitive/non-competitive micromosaic immunoassay. |
| Q39241323 | Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115 |
| Q44430840 | Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes |
| Q37177309 | Does Quercetin Improve Cardiovascular Risk factors and Inflammatory Biomarkers in Women with Type 2 Diabetes: A Double-blind Randomized Controlled Clinical Trial |
| Q44927546 | Early vitamin E supplementation attenuates diabetes-associated vascular dysfunction and the rise in protein kinase C-beta in mesenteric artery and ameliorates wall stiffness in femoral artery of Wistar rats. |
| Q30784223 | Effect of pravastatin on responsiveness to N-monomethyl-L-arginine in patients with hypercholesterolaemia |
| Q80505490 | Endothelial dysfunction in diabetes mellitus |
| Q35087390 | Endothelial dysfunction in human diabetes |
| Q43703668 | Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in men with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance |
| Q61454282 | Erectile Dysfunction and Ischaemic Heart Disease |
| Q36423886 | Fabrication and Characterization of a Glucose-sensitive Antibacterial Chitosan-Polyethylene Oxide Hydrogel |
| Q36710482 | Healthy endothelium: the scientific basis for cardiovascular health promotion and chronic disease prevention |
| Q35214644 | Insulin resistance and endothelial dysfunction |
| Q34960365 | Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications |
| Q36359837 | Linking erectile dysfunction and coronary artery disease |
| Q35047134 | Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? |
| Q35989396 | Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. |
| Q34310277 | Pathophysiology of oxidative stress in diabetes mellitus |